Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52
Open accessThe DOI matches its Crossref record.
Abstract
Purpose: Tumor protein D52 (TPD52 or D52) is frequently overexpressed in breast and other cancers and present at increased gene copy number. It is, however, unclear whether D52 amplification and overexpression target specific functional properties of the encoded protein. Experimental Design: The expression of D52-like genes and MAL2 was compared in breast tissues using quantitative reverse transcription-PCR. The functions of human D52 and D53 genes were then compared by stable expression in BALB/c 3T3 fibroblasts and transient gene knockdown in breast carcinoma cell lines. In situ D52 and MAL2 protein expression was analyzed in breast tissue samples using tissue microarray sections. Results: The D52 (8q21.13), D54 (20q13.33), and MAL2 (8q24.12) genes were significantly overexpressed in breast cancer tissue (n = 95) relative to normal breast (n = 7; P ≤ 0.005) unlike the D53 gene (6q22.31; P = 0.884). Subsequently, D52-expressing but not D53-expressing 3T3 cell lines showed increased proliferation and anchorage-independent growth capacity, and reduced D52 but not D53 expression in SK-BR-3 cells significantly increased apoptosis. High D52 but not MAL2 expression was significantly associated with reduced overall survival in breast carcinoma patients (log-rank test, P < 0.001; n = 357) and was an independent predictor of survival (hazard ratio, 2.274; 95% confidence interval, 1.228-4.210; P = 0.009; n = 328). Conclusion: D52 overexpression in cancer reflects specific targeting and may contribute to a more proliferative, aggressive tumor phenotype in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sun, Q., Zhou, W.-X., & Fan, J. (2020) · Journal of the American Statistical Association · doi:10.1080/01621459.2018.1543124 · Cited by 312
Biesemann, C., Grønborg, M., Luquet, E., Wichert, S. P., Bernard, V., Bungers, S. R., Cooper, B., Varoqueaux, F., Li, L., Byrne, J. A., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386120 · Cited by 156
“…BD Transduction Labs), GAD67 (Millipore, 1:2,000), GAD65 (Millipore, 1:1,000), GFAP (1:500; Dako), MAP2 (Millipore, 1:2,000); rabbit polyclonal antisera to GFP (A6455, Invitrogen, 1:5,000), VIAAT (Synaptic Systems, 1:1,000), Tpd52 (1:300; Shehata et al, 2008), FXYD6 (1:2,000; Delprat et al, 2007).”
Self-citationExosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Ubanako, P., Mirza, S., Ruff, P., & Penny, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1447953 · Cited by 68
Byrne, J. A., & Labbé, C. (2017) · Scientometrics · doi:10.1007/s11192-016-2209-6 · Cited by 50
“Based on past experience (Roslan et al. 2014; Shehata et al. 2008), the core experiments described by index studies (Tables 1, 2) could require 6 months–1 year of laboratory work.”
MethodSelf-citationAnalysis of intracellular and intercellular crosstalk from omics data
Chiodi, A., Pelucchi, P., & Mosca, E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552776
Metadata
- Authors
- Shehata, M., Bièche, I., Boutros, R., Weidenhofer, J., Fanayan, S., Spalding, L., Zeps, N., Byth, K., Bright, R. K., Lidereau, R., & Byrne, J. A.
- Venue
- Clinical Cancer Research
- Published
- 2008-08-12
- Volume
- 14
- Issue
- 16
- Pages
- 5050-5060
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2106843579
- Cited by
- 66
- References
- 0
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-07-4994
- The paper
- Shehata, M., Bièche, I., Boutros, R., Weidenhofer, J., Fanayan, S., Spalding, L., Zeps, N., Byth, K., Bright, R. K., Lidereau, R., & Byrne, J. A. (2008). Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-07-4994
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.